An anti-TNF-antibody-cytokine fusion combo with chemotherapy turns inoperable brain tumours hot in mice. A Phase I trial sponsored by Philogen SpA is underway.
https://european-biotechnology.com/wp-content/uploads/2024/04/Glioblastoma_Christaras_A_wikimedia.com.jpeg778800Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-05-25 07:27:002024-07-12 11:16:37Glioma drug combo turns tumours hot